A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Company Overview Pro-Dex, Inc. (“Company,” “Pro-Dex,” “we,” “our,” “us”) specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial (“CMF”) markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries; however, these motors comprise a de minimis portion of our business. Our patented adaptive torque-limiting software has been very well received in the CMF and thoracic markets and we have continued investment in this area with research and development focused on applying this technology to other surgical applications. In November 2020, we purchased an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”).
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 72M | 67M | 54M | 46M | 42M | 38M |
| Net Income | 11M | 9.0M | 2.1M | 7.1M | 4.6M | 5.8M |
| EPS | $3.41 | $2.67 | $0.60 | $1.95 | $1.21 | $1.48 |
| Free Cash Flow | 0 | -1.7M | 6.2M | -1.0M | -2.5M | -3.8M |
| ROIC | 18.4% | 15.6% | 13.0% | 9.8% | 10.1% | 12.9% |
| Gross Margin | 28.3% | 29.3% | 27.0% | 27.7% | 31.2% | 35.7% |
| Debt/Equity | 0.31 | 0.76 | 0.67 | 0.52 | 0.66 | 0.70 |
| Dividends/Share | $0.00 | - | - | - | - | $0.00 |
| Operating Income | 11M | 11M | 7.2M | 5.8M | 5.1M | 4.5M |
| Operating Margin | 15.7% | 16.1% | 13.3% | 12.5% | 12.2% | 11.9% |
| ROE | 27.2% | 26.6% | 6.9% | 22.4% | 18.0% | 29.0% |
| Shares Outstanding | 3M | 3M | 4M | 4M | 4M | 4M |
PRO DEX INC passes 5 of 9 quality checks, suggesting mixed fundamentals.
PRO DEX INC trades at 19.6x trailing earnings, compared to its 15-year median P/E of 13.4x, suggesting it is currently Fair relative to its historical range. The company's 5-year average ROIC is 12.3% with a gross margin of 30.2%. Total shareholder yield (buybacks) is 2.1%. At current prices, the estimated annualized return to fair value is +11.0%.
PRO DEX INC (PDEX) has a current P/E ratio of 19.6, compared to its historical median P/E of 13.4. The stock is currently considered Fair based on its historical valuation range.
PRO DEX INC (PDEX) has a 5-year average return on invested capital (ROIC) of 12.3%. This indicates solid capital allocation.
PRO DEX INC (PDEX) has a market capitalization of $168M. It is classified as a small-cap stock.
PRO DEX INC (PDEX) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 2.09%.
Based on historical P/E analysis, PRO DEX INC (PDEX) appears fair. The current P/E of 19.6 is 47% above its historical median of 13.4. The estimated fair value CAGR (P/E method) is 10.2%.
PRO DEX INC (PDEX) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
PRO DEX INC (PDEX) reported annual revenue of $67 million in its most recent fiscal year, based on SEC EDGAR filings.
PRO DEX INC (PDEX) has a net profit margin of 13.5%. This is a healthy margin.
PRO DEX INC (PDEX) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
PRO DEX INC (PDEX) has a debt-to-equity ratio of 0.76. This indicates moderate leverage.
PRO DEX INC (PDEX) reported earnings per share (EPS) of $2.67 in its most recent fiscal year.
PRO DEX INC (PDEX) has a return on equity (ROE) of 26.6%. This indicates the company generates strong returns for shareholders.
PRO DEX INC (PDEX) has a 5-year average gross margin of 30.2%. This indicates decent pricing power.
The Ledger Terminal provides 15 years of financial data for PRO DEX INC (PDEX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
PRO DEX INC (PDEX) has a book value per share of $10.89, based on its most recent annual SEC filing.
No recent press releases.